Back to School: How biopharma can reboot drug development. Access exclusive analysis here

0919 azar memo
BioCentury & Getty Images

Politics, Policy & Law

Azar clips wings of FDA, CDC, NIH and other health agencies

HHS memo raises alarms from former agency heads

Sep 19, 2020 | 11:00 PM GMT

In a move that former government officials are interpreting as a power grab that could signal a reduction in the ability of public health agencies to act independently, HHS

Read the full 629 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE